Simmonds, P, et al.
A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology
1994; 19: 1321–1324.
McOmish, F, et al.
Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey. Journal of Clinical Microbiology
1994; 32: 884–892.
Tanaka, H, et al.
Hepatitis C virus 1b (II) infection and development of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma: a case-control study in Japan. Journal of Epidemiology
1998; 8: 244–249.
Ghany, MG, et al.
Diagnosis, management, and treatment of hepatitis C: an update. Hepatology
2009; 49: 1335–1374.
Moriya, T, et al.
Epidemiology of hepatitis C virus in Japan. Intervirology
1999; 42: 153–158.
Ohno, T, et al.
New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a. Journal of Clinical Microbiology
1997; 35: 201–207.
Rosen, HR, et al.
Molecular epidemiology of hepatitis C infection in U.S. veterans liver transplant recipients: evidence for decreasing relative prevalence of genotype 1B. American Journal of Gastroenterology
1999; 94: 3015–3019.
Bourliere, M, et al.
Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users. Journal of Viral Hepatitis
2002; 9: 62–70.
Chlabicz, S, et al.
Changing HCV genotypes distribution in Poland – relation to source and time of infection. Journal of Clinical Virology
2008; 42: 156–159.
Mathei, C, et al.
Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours. European Journal of Clinical Microbiology and Infectious Diseases
2005; 24: 514–522.
Roman, F, et al.
Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006. World Journal of Gastroenterology
2008; 14: 1237–1243.
Bojovic, K, et al.
The comparison of chronic hepatitis C treatment outcome between intravenous drug users and non-intravenous drug users. Biomedicine and Pharmacotherapy
2013; 67: 517–520.
Chung, H, Ueda, T, Kudo, M. Changing trends in hepatitis C infection over the past 50 years in Japan. Intervirology
2010; 53: 39–43.